[The diagnostic value of RNA oncomarkers in evaluation of malignant breast tumors].

Autor: Globa AG, Alekseev IaI, Varlamov DA, Vishnevskiĭ AA
Jazyk: ruština
Zdroj: Biomeditsinskaia khimiia [Biomed Khim] 2011 Nov-Dec; Vol. 57 (6), pp. 677-80.
DOI: 10.18097/pbmc20115706677
Abstrakt: The levels of the RNA oncomarkers, telomerase (hTERT), cytokeratin-19 (CK-19) and mammaglobin (MAM) have been investigated in capillary blood of female patients with mammary ductal carcinoma. The study revealed overexpression of all three factors in patients with this pathology. This overexpression was not found in healthy donors and female patients with mammary fibroadenoma. Levels of the RNA oncomarkers return to the normal level within 10 days after successful tumor resection. These results have been used for the development of diagnostic kits, which may be applicable for differential diagnostics, screening and postoperation monitoring of patients with malignant breast tumors
Databáze: MEDLINE